Overview
EMBL Ventures is an independent venture capital investor that manages two Funds with a total of €66 million capital on behalf of major European institutional and private investors. EMBL Ventures' close relationship with the European Molecular Biology Laboratory (EMBL) and its technology transfer organization EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) allows it to finance disruptive technologies in an entrepreneurial start-up environment, aiming ultimately for a transaction with a partner that is seeking to acquire external product innovation. EMBL Ventures is exclusively focused on life-science investments.
"EMBL Ventures has played a crucial role in building Elara Pharmaceuticals from an academic project to an established Biotech company. The excellent support and access to their network has smoothed the process of building the company and its capabilities. I would certainly recommend anyone who is thinking of starting a company to get EMBL Ventures involved."
Joe Lewis, PhD; CEO, Elara Pharmaceuticals, Heidelberg